Acadia Healthcare Company, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Acadia Healthcare Company, Inc. filed its Q2 2026 Form 10-Q, detailing revenue, expenses, and operational performance.
NASDAQ
Acadia Healthcare Company, Inc. reported a significant decline in net income for the third quarter and first nine months of 2025, primarily driven by a sharp increase in legal and government investigation costs, despite revenue growth.
NASDAQ
Acadia Healthcare Company, Inc. reported a significant drop in net income for Q2 2025, primarily driven by a surge in legal and government investigation expenses, despite strong revenue growth.
NASDAQ
Acadia Healthcare's Q1 2025 results show a slight revenue increase but a significant decrease in net income due to higher expenses related to legal settlements and government investigations.
NASDAQ
Acadia Healthcare Company, Inc. announced its third-quarter 2024 results, showing an 8.7% increase in revenue compared to the same period last year, alongside updates on legal proceedings and financial performance.
NASDAQ
Acadia Healthcare Company, Inc. announced an 8.8% revenue increase for the first half of 2024, driven by growth in patient days and revenue per patient day, alongside strategic bed expansion.
NASDAQ
Acadia Healthcare's first quarter 2024 revenue increased by 9.1% year-over-year, driven by growth in same-facility revenue and patient days.